Top Markets
Coin of the day
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.

TFF Pharmaceuticals, Inc.

TFFP
Pozycja w akcjach #40710
Operating as a clinical-stage biopharmaceutical company, TFF Pharmaceuticals,... Operating as a clinical-stage biopharmaceutical company, TFF Pharmaceuticals, Inc., leverages its proprietary Thin Film Freezing (TFF) technology platform for the advancement and commercialization of therapeutic products across the United States and Australia. A primary emphasis is placed on creating inhaled dry powder formulations to address various pulmonary ailments and disorders. Its two leading drug candidates, both currently in Phase II clinical trials, include TFF Voriconazole Inhalation Powder, designed to combat invasive pulmonary aspergillosis, and TFF Tacrolimus Inhalation Powder, aimed at preventing lung transplant rejection. Beyond these, the company's pipeline features other dry powder products like a cannabidiol substance targeting various epilepsy syndromes, anxiety, insomnia, and pain; an Inhaled SARS-CoV2 Monoclonal Antibody for COVID-19 patients; Niclosamide Inhalation Powder, intended for human tapeworm infections and COVID-19; and a range of other vaccines. Strategic partnerships are also central to its operations, including a licensing arrangement with the University of Texas at Austin for inhaled dry powder drug development, a joint development pact with Augmenta Bioworks, Inc. for the inhaled SARS-CoV2 monoclonal antibody, and a broad licensing and collaboration agreement with UNION therapeutics A/S. Established in 2018, the company maintains its headquarters in Austin, Texas.
Cena akcji
$0.065
Ostatnia synchronizacja: 2025-01-10
Kapitalizacja rynkowa
$94.10K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel TFF Pharmaceuticals, Inc. (TFFP)

Kategoria

Cena TFFP z kapitalizacją rynkową B
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
TFFP
$0.065
Kapitalizacja rynkowa TFF Pharmaceuticals, Inc.(TFFP)
Kapitalizacja rynkowa: $94.10K
Na dzień August 2026 spółka TFF Pharmaceuticals, Inc. ma kapitalizację rynkową wynoszącą $94.10K. Według naszych danych, czyni to TFF Pharmaceuticals, Inc. 40710th najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej TFF Pharmaceuticals, Inc. od 2019 do 2026
TFFP w porównaniu do 5 najpopularniejszych stocks
Cena za TFFP Aktywa B Kapitalizacja rynkowa B Wyniki
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$3,775,383 $94.10K
$5.466T +5,808,281,050.57%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$3,077,935 $94.10K
$4.456T +4,735,284,137.96%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$2,883,583 $94.10K
$4.175T +4,436,281,069.66%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$2,547,265 $94.10K
$3.688T +3,918,868,801.49%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$1,978,704 $94.10K
$2.865T +3,044,160,226.98%